Form: Tablets
Packaging: 20 film-coated tablets

Active substance:  paracetamol – phenylephrine – chlorphenamine

Form : film-coated tablets

Dosage per tablet :

  • Paracetamol 650 mg
  • phenylephrine 10 mg
  • chlorphenamine 4 mg

Packaging : bow containing 20 tablets

Target : Adults, adolescents et children as from 12 y of age

Relief of symptoms in catarrhal or flu-related conditions with pain (mild or moderate), fever, nasal congestion and discharge (stuffy and runny nose), sneezing and allergic rhinitis.

These symptoms can occur in coryza, influenza, colds, rhinitis, pharyngitis, sinusitis, bronchitis, laryngitis, seasonal allergies (the seasonal cold), perennial rhinitis, rhinosinusitis.

The usual dose: 1 tablet administered with an interval of at least 6 hours, corresponding to a maximum of 4 tablets per day.

Over-the-counter drug

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo (https://www.dafrapharma-vet.com/). In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma